AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

NCT00427349 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
46
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

Eastern Cooperative Oncology Group

Collaborators